查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
骨密度测定係统市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190127

骨密度测定係统市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Bone Densitometer Systems Market - Growth, Trends, and Forecasts (2023- 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，骨密度测定係统市场预计将以 3.5% 的复合年增长率增长。

COVID-19 大流行对骨密度测定係统市场产生了重大影响。 COVID-19 疾病和治疗对倖存患者的骨骼健康产生不利影响，影响了市场的增长速度。 根据国家医学图书馆 2022 年 4 月发表的一篇论文，COVID-19 的急性后遗症可导致继发性骨质疏鬆症。 为了帮助及早发现和治疗骨质疏鬆症问题，我们正在广泛调查随访中 COVID-19 住院倖存患者的骨骼健康状况。 随着COVID-19患者的增加，骨密度的早期检测和骨检查增加，增加了对骨密度仪的需求。

骨关节炎和维生素缺乏症患病率的上升、骨密度测定的日益普及以及技术进步是推动骨密度测定係统市场增长的主要因素。 例如，根据关节炎社区研究和评估单位 (ACREU) 发表的一篇文章，2021 年大约 15% 的 20 岁以上的加拿大人将患有骨关节炎。 此外，超过 400 万加拿大人，即大约七分之一的成年人患有骨关节炎。 如此高的疾病负担预计将增加对用于准确诊断的骨密度测量系统的需求，并最终推动市场增长。 Clilactic 发表的一项研究发现，到 2022 年 1 月，骨质疏鬆症每年将导致超过 890 万例骨折，全球每三秒钟就有一例骨质疏鬆性骨折发生。 据估计，骨质疏鬆症影响着全世界 2 亿妇女。

此外，各种医疗保健提供商采用骨密度计也有助于市场增长。 例如，2021 年 6 月，Healthshare Group 旗下的伦敦 Riverside Clinic 采用 Fujifilm 的 DXA 解决方案进行骨质疏鬆症诊断社区试验。

骨关节炎和维生素缺乏症的患病率上升、骨密度计的使用率增加以及技术进步等因素正在推动骨密度计系统市场的增长。 然而，与骨密度计相关的风险及其高成本可能会限制市场增长。

主要市场趋势

双能 X 射线吸收测定 (DEXA) 细分市场预计在预测期内实现高速增长

在轴向骨密度测定中，双能 X 射线吸收测定法 (DEXA) 是评估体内骨密度的最广泛使用的技术。 该设备用于中心和外周骨矿物质密度 (BMD) 扫描，由于其高精度、易于操作以及对成人和儿童安全而得到广泛使用。 双能 X 射线吸收测定法（DEXA 或 DXA）用于诊断骨质减少和骨质疏鬆症。 由于骨质疏鬆症的患病率很高，人们认为患病率的增加是由于能够满足临床医生的不同需求。

此外，持续的技术发展，例如数字检测器和计算机辅助超声波密度计的集成，展示了高舒适度、可操作性和缩短的测量时间。 例如，2022年2月，Echolight Medical与Aurora Spine Corporation签订了合作联合营销协议。 Aurora 使用 DEXA 技术开发和製造脊柱植入物，Echolight 使用非电离辐射进行骨骼健康评估业务。 此外，2022 年 1 月，贝克曼库尔特在迪拜世界贸易中心举办的 2022 MEDLAB Middle East 上展出了已发布的工作流自动化系统 DxA 5000 Fit。 因此，所有这些技术进步、发布和合作战略都有望促进目标市场的增长。

双能 X 射线吸收测定法的采用率提高等因素预计将在预测期内推动市场的细分增长。

北美地区在预测期内将主导骨密度测量系统市场

由于各地区公司为提高研发能力和保持高标准的医疗保健而开展的各种合作，预计北美市场份额很大，从而推动了整个地区的需求。 美国的骨密度测定係统市场受到医疗保健系统中先进技术越来越多的使用以及该国慢性病负担不断增加的推动。 例如，根据美国癌症协会2022年的统计，2022年美国估计将有3910例骨关节癌新发病例，其中女性1750例，男性2160例。 癌症是骨质流失和骨折的主要因素，因为癌细胞直接影响身体的骨骼，而抗癌药物会对骨细胞产生不利影响。 增加的癌症负担也促进了该地区的市场增长，因为骨密度计系统有助于评估骨折风险。

此外，2021 年加拿大骨关节炎负担报告指出，骨关节炎的患病率随着年龄的增长而增加。 另据报导，超过一半（52%）的加拿大骨关节炎患者年龄在 65 岁以下。 同一份文件还报告说，超过 400 万加拿大人，即大约七分之一的成年人患有骨关节炎。 因此，随着慢性病的增多，医疗机构对准确诊断和高效及时的治疗规划的需求越来越大。 因此，该地区的研究目标市场预计在未来几年将会增长。

此外，由于该地区老年人口的增加，市场有望扩大。 例如，加拿大统计局的 2021 年人口普查发现，65 岁及以上的人口大约有 7,021,430 人，其中男性 3,224,680 人，女性 3,796,750 人。 由于老年人最容易患上各种与年龄相关的骨骼疾病，因此医疗机构对骨密度测定係统的需求不断增加，预计将推动市场增长。

因此，由于医疗保健系统中先进技术的使用增加和慢性病负担增加等因素，预计北美地区的市场在预测期内将出现增长。

竞争格局

由于公司在全球和区域开展业务，骨密度测定係统市场规模不大。 竞争格局是GE Healthcare, Hologic, Beamed, DMS Imaging, Swiss Ray International, Singaoy Medical Devices, Eurotech Medical Systems SRL, Tribitron Healthcare, Scanflex Healthcare AB, Mednica, Osteosys, Cyber□□ Analysis等国际组织以及当地知名企业包括 Logic、MEDILINK、Osteometer Meditech、CompuMed、Echolight S.p.a 和 Eurotech Medical Systems SRL 等公司。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 骨质疏鬆症和维生素 D 缺乏症的发病率增加
    • 提高骨密度计的普及率
    • 骨密度测定领域的技术进展
  • 市场製约因素
    • 与骨密度计相关的风险
    • 骨密度计成本高
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按技术
    • 轴向骨密度计
      • 双能 X 射线吸收测定法 (DEXA)
      • 定量计算机断层扫描 (QCT)
    • 外周骨密度测定
      • 单能 X 射线吸收测定法 (SEXA)
      • 双能 X 射线吸收测定法 (pDEXA)
      • 辐射吸收测量 (RA)
      • 定量超声 (QUS)
      • 外周定量计算机断层扫描 (pQCT)
  • 最终用户
    • 医院
    • 专科诊所
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • GE Healthcare
    • Hologic Inc.
    • Beammed Ltd.
    • DMS Imaging
    • Swissray International, Inc.
    • MEDILINK
    • Osteometer MediTech
    • CompuMed, Inc.
    • Echolight S.p.a
    • Eurotec Medical Systems srl
    • Xingaoyi Medical Equipment Co. Ltd
    • Trivitron Healthcare
    • Scanflex Healthcare AB
    • Medonica Co. LTD
    • OsteoSys Corp

第7章 市场机会今后动向

简介目录
Product Code: 67159

The bone densitometer systems market is expected to register a CAGR of 3.5% over the forecast period.

The COVID-19 pandemic impacted the bone densitometer systems market significantly. The COVID-19 illness and treatment adversely affected the bone health of surviving patients, affecting the market's growth pace. According to an article published by the National Library of Medicine in April 2022, post-acute sequela of COVID-19 can cause secondary osteoporosis. To help with the early detection and treatment of osteoporosis problems, the bone health status of patients who survived COVID-19 hospitalization was extensively examined at subsequent visits. With the increased number of COVID-19 patients, the early detection of bone density and bone examination increased, leading to increased demand for bone densitometers.

The rising prevalence of osteoarthritis and vitamin deficiencies, increased adoption of bone densitometers, and technological advancements are key factors fueling the bone densitometer systems market growth. For instance, according to an article published by the Arthritis Community Research and Evaluation Unit (ACREU), in 2021 around 15% of Canadians aged 20 years and above had osteoarthritis. The report further stated that more than 4 million Canadians, or about one in every seven adults, have osteoarthritis. The high burden of such disorders is expected to boost the demand for bone densitometer systems for accurate diagnosis, ultimately driving market growth. According to a study published by Climacteric, in January 2022, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds, globally. It is estimated that osteoporosis affects 200 million women worldwide.

Additionally, the adoption of bone densitometers by various healthcare providers also contributes to the growth of the market. For instance, in June 2021, the Riverside Clinic in London, part of the Healthshare Group, chose Fujifilm's DXA Solution for the community trial to diagnose osteoporosis.

Factors such as rising prevalence of osteoarthritis and vitamin deficiencies, increased adoption of bone densitometers and technological advancements are driving the market growth for the bone densitometer systems market. However, risks associated with bone densitometers and the high cost of it may restrain the market growth.

Key Market Trends

Dual Energy X-ray Absorptiometry (DEXA) Segment is Expected to Witness High Growth Over the Forecast Period

In axial bone densitometry, dual-energy X-ray absorptiometry (DEXA) is the most widely used technique for assessing bone density in the body. This device is used for both central and peripheral bone mineral density (BMD) scans and is widely used due to its high precision, easy handling, and safety of usage for adults and children. Dual-energy x-ray absorptiometry (DEXA or DXA) is used to aid in diagnosing osteopenia and osteoporosis. The increasing adoption rate can be attributed to the fulfillment of different requirements of clinicians by dual-energy x-ray absorptiometry, as there is a high prevalence of osteoporosis in the population.

Furthermore, consistent technological developments, such as integrating digital detectors and computer-assisted and ultrasonic densitometers, have been proven to have high comfort, ease of operation, and reduced measuring time. For instance, in February 2022, Echolight Medical and Aurora Spine Corporation engaged in a cooperative co-marketing agreement. Aurora is engaged in developing and manufacturing DEXA Technology-based Spinal Implants, while Echolight is in the business of non-ionizing radiation bone health assessment. Additionally, in January 2022, Beckman Coulter displayed its launched DxA 5000 Fit workflow-automation system at the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre. Hence, all these technological advancements, launches, and partnership strategies are expected to lead to the target market's growth.

Factors such as the increasing adoption rate of Dual-energy x-ray absorptiometry are expected to drive segmental growth in the market during the forecast period.

North America Region is Dominating the Bone Densitometer Systems Market Over the Forecast Period

North America has accounted for a large market share due to the various collaborative efforts undertaken by various regional companies to improve their R&D capabilities and maintain high medical standards, which are expected to propel the demand across this region. The market for bone densitometer systems in United States is being driven by the increasing use of advanced technology in healthcare systems and the rising burden of chronic diseases in the country. For instance, according to the American Cancer Society's 2022 statistics, it is estimated that in United States, there are a total of 3,910 new cases of bone and joint cancer, out of which 1,750 are females and 2,160 are males in 2022. Cancer is a significant contributor to bone loss and fractures since cancer cells directly impact the body's skeleton and cancer-specific medicines have adverse effects on bone cells, since the bone densitometer system helps in assessing the risk of fractures, the rising burden of cancer also contributes to the growth of the market in the region.

Additionally, the Burden of Osteoarthritis in Canada, 2021 report, stated that the prevalence of osteoarthritis rises with age. It also reported that more than half (52%) of Canadians who have osteoarthritis are younger than 65. The same source also reported that more than 4 million Canadians, or about 1 in every 7 adults, have osteoarthritis. Therefore, the increased prevalence of chronic diseases increases the demand for accurate diagnosis and a treatment plan that is both efficient and timely from healthcare providers. As a result, the studied market in the region is expected to grow over the coming years.

Furthermore, the market is predicted to grow due to the growing elderly population in the region. For instance, as per Statistics Canada's 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females. As the aged population is most vulnerable to various age-related bone diseases, the demand for bone densitometer systems at healthcare facilities is anticipated to increase, propelling market growth.

Thus, owing to the factors such as increasing use of advanced technology in healthcare systems and the rising burden of chronic diseases, the studied market in the North American region is expected to project growth over the forecast period.

Competitive Landscape

The bone densitometer systems market is moderate due to the presence of companies operating globally and regionally. The competitive landscape includes an analysis of international as well as local companies well known including GE Healthcare, Hologic Inc., Beammed Ltd., DMS Imaging, Swissray International, Inc., Xingaoyi Medical Equipment Co. Ltd., Eurotec Medical Systems Srl, Trivitron Healthcare, Scanflex Healthcare AB, Medonica Co. Ltd., OsteoSys Corp, CyberLogic, Inc., MEDILINK, Osteometer MediTech, CompuMed, Inc., Echolight S.p.a, and Eurotec Medical Systems SRL., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surge in Incidence of Osteoporosis and Vitamin D Deficiency
    • 4.2.2 Increase in Adoption of Bone Densitometers
    • 4.2.3 Technological Advancements in the Field of Bone Densitometry
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Bone Densitometers
    • 4.3.2 High Cost of Bone Densitometers
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Technology
    • 5.1.1 Axial Bone Densitometry
      • 5.1.1.1 Dual energy X-ray absorptiometry (DEXA)
      • 5.1.1.2 Quantitative computed tomography (QCT)
    • 5.1.2 Peripheral Bone Densitometry
      • 5.1.2.1 Single Energy X-Ray Absorptiometry (SEXA)
      • 5.1.2.2 Dual Energy X-Ray Absorptiometry (pDEXA)
      • 5.1.2.3 Radiographic Absorptiometry (RA)
      • 5.1.2.4 Quantitative Ultrasound (QUS)
      • 5.1.2.5 Peripheral Quantitative Computed Tomography (pQCT)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Specialty Clinics
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GE Healthcare
    • 6.1.2 Hologic Inc.
    • 6.1.3 Beammed Ltd.
    • 6.1.4 DMS Imaging
    • 6.1.5 Swissray International, Inc.
    • 6.1.6 MEDILINK
    • 6.1.7 Osteometer MediTech
    • 6.1.8 CompuMed, Inc.
    • 6.1.9 Echolight S.p.a
    • 6.1.10 Eurotec Medical Systems srl
    • 6.1.11 Xingaoyi Medical Equipment Co. Ltd
    • 6.1.12 Trivitron Healthcare
    • 6.1.13 Scanflex Healthcare AB
    • 6.1.14 Medonica Co. LTD
    • 6.1.15 OsteoSys Corp

7 MARKET OPPORTUNITIES AND FUTURE TRENDS